Does lingonberry help prevent urinary tract infections?

Most fruits get their antioxidant credit from anthocyanins — the pigments that color blueberries blue and raspberries red. Lingonberries have those too, but their dominant polyphenol class is proanthocyanidins, which make up roughly 63 to 71 percent of total phenolics in the fruit¹. These are the same A-type proanthocyanidins (PACs) that make cranberries useful for urinary tract health, and chemically the two berries are nearly interchangeable for that purpose^1,2.

Beyond PACs, lingonberries are notable for their content of:

• Quercetin and quercetin glycosides — flavonoids with anti-inflammatory and antihistamine activity. See our Quercetin page for a deeper dive on these compounds.
• Resveratrol — the same polyphenol that made red wine famous, present at meaningful levels in lingonberry skin⁷.
• Arbutin — a compound studied for its effects on skin pigmentation and as a mild urinary antiseptic.
• Hydroxycinnamic acids — caffeoylquinic and ferulic acid conjugates that contribute to antioxidant capacity.

Total polyphenol content is among the highest of any commonly eaten fruit, often cited at 600 to 700 mg per 100 grams of fresh berries — roughly two to three times the level in blueberries.

Urinary Tract Health

The most established human use for lingonberry is the prevention of recurrent urinary tract infections, almost always in combination with cranberry. The landmark trial — Kontiokari and colleagues in BMJ — randomized 150 women who had just been treated for an E. coli urinary tract infection into three groups: a daily cranberry-lingonberry juice concentrate, a Lactobacillus drink, or no intervention². After six months, only 16 percent of the cranberry-lingonberry group had a recurrence, compared with 36 percent in the control group — a roughly 20-percentage-point absolute reduction.

The mechanism is mechanical, not antibiotic: the A-type PACs bind to the P-fimbriae of uropathogenic E. coli and prevent the bacteria from anchoring to the bladder lining, so they get flushed out in urine¹. Because there is no killing involved, this effect does not contribute to antibiotic resistance and can be used continuously. See our Cranberry page for the broader UTI evidence base, which is highly applicable to lingonberry as well.

Blood Sugar and Metabolic Effects

One of the more surprising findings about lingonberries is that they appear to neutralize the glycemic impact of their own sugars. In a controlled crossover study in healthy adults, eating lingonberries together with a glucose load produced a flatter blood-sugar curve than glucose alone — even though the berries themselves contain fructose and glucose³. The fiber and polyphenols in the whole berry seem to slow carbohydrate absorption enough to offset the sugar they deliver.

In animal studies, lingonberry supplementation against a high-fat diet has consistently:

• Prevented weight and visceral fat gain⁶
• Lowered fasting glucose and improved glucose tolerance⁶
• Reduced circulating leptin and inflammatory markers like serum amyloid A⁴
• Modified the gut microbiota toward a leaner, less inflammatory profile, with increases in Akkermansia muciniphila and Faecalibacterium — both bacteria associated with metabolic health⁴

These mouse studies do not prove the same effects in humans, but the consistency across endpoints — weight, glucose, lipids, inflammation, and microbiome — makes lingonberry one of the more interesting whole foods for metabolic syndrome research.

Inflammation and Blood Vessels

Lingonberry polyphenols act on inflammation through several pathways. In cell studies, the polyphenol fraction reduces reactive oxygen species in hypertrophied fat cells and dampens inflammatory gene expression in vascular endothelial cells, both of which are early steps in the development of atherosclerosis⁵. Resveratrol, kaempferol, and proanthocyanidins from lingonberry also push macrophages toward an anti-inflammatory M2 phenotype rather than the pro-inflammatory M1 state that drives chronic disease⁷.

Practical Use

Lingonberries are intensely tart and almost never eaten raw in quantity. The most common forms are:

• Lingonberry preserves or jam — the Scandinavian default. Look for low-sugar versions; many commercial preserves are essentially sugar with berries added.
• Frozen whole berries — the cleanest way to get the polyphenols. Stir into yogurt, oatmeal, or smoothies.
• Lingonberry juice — usually diluted because of the tartness. Useful for the UTI-prevention dose; aim for an unsweetened or lightly-sweetened concentrate.
• Dried lingonberries — convenient but lower in polyphenol content than fresh or frozen.
• Lingonberry powder or extract — used in supplements, often standardized to PAC content similar to cranberry extract.

For UTI prevention, the dose used in the Kontiokari trial was 50 mL of cranberry-lingonberry juice concentrate daily². For general antioxidant and metabolic support, the studies that have shown effects in humans used roughly a half-cup serving of berries per day.

There are no significant safety concerns at culinary doses. People on warfarin should be cautious with large amounts of any berry juice, since polyphenols can interact with anticoagulants.

Polyphenol Composition and Anti-Adhesion (Kylli et al., 2011)

The Kylli proanthocyanidin paper established the chemical foundation for lingonberry's parallel use with cranberry¹. Working from purified PAC fractions, the authors identified procyanidins A1, A2, A4, B1, B2, B3, and C1 in lingonberry, with A-type linkages dominating — the same structural feature that gives cranberry PACs their anti-adhesion effect against uropathogenic E. coli. Total proanthocyanidins accounted for up to 50 percent of identified phenolics across the berry's vegetative stages. The authors directly demonstrated bacterial anti-adhesion activity, providing in-vitro confirmation that the mechanism translates from cranberry to lingonberry.

UTI Prevention Trial (Kontiokari et al., 2001)

The Kontiokari BMJ trial remains the most direct human evidence for lingonberry's role in urinary tract health². The three-arm randomized design enrolled 150 women within one week of completing antibiotic treatment for an E. coli UTI:

• Cranberry-lingonberry group (n=50): 50 mL of juice concentrate daily for 6 months (equivalent to 7.5 g cranberry concentrate plus 1.7 g lingonberry concentrate per dose)
• Lactobacillus group (n=50): 100 mL of Lactobacillus GG drink five days per week for one year
• Control group (n=50): no intervention

At six months, recurrence rates were 16 percent in the cranberry-lingonberry group, 39 percent in the Lactobacillus group, and 36 percent in the control group. The cumulative hazard of first recurrence over twelve months differed significantly between groups (P=0.048). The relative risk reduction in the berry group was approximately 56 percent compared with control. The trial does not isolate the lingonberry contribution from the cranberry contribution, which is the main limitation; the active mechanism is plausibly attributable to PACs from either source.

Glycemic Modulation in Healthy Humans (Linderborg et al., 2012)

In a tightly controlled crossover study, Linderborg and colleagues fed healthy adults either a glucose drink alone or the same glucose load served with whole lingonberries³. Postprandial glucose, insulin, and free fatty acid responses were measured at intervals over the following hours. The lingonberry condition produced a significantly lower glucose peak and area-under-the-curve despite the berries themselves containing roughly 7 grams of additional sugar per serving. The authors attributed the effect to the combination of soluble fiber and polyphenols slowing glucose uptake. The study is small but mechanistically clean — it isolates the matrix effect of the berry on a known sugar challenge.

Gut Microbiota and Inflammation (Heyman-Lindén et al., 2016)

The Heyman-Lindén study fed C57BL/6 mice a high-fat diet with or without lingonberry supplementation for eleven weeks⁴. Lingonberry-fed mice showed:

• 36 percent reduction in circulating leptin
• 85 percent reduction in serum amyloid A (an acute-phase inflammation marker)
• Marked shifts in gut microbiota composition, including increases in Akkermansia muciniphila and Faecalibacterium prausnitzii — two species repeatedly associated with metabolic health and intestinal barrier integrity
• Altered expression of intestinal genes involved in barrier function and lipid metabolism

The study is animal-only, which limits direct extrapolation, but the convergence of microbial, inflammatory, and barrier-function endpoints makes it a more substantive mechanistic finding than a single-marker readout.

Endothelial and Adipocyte Effects (Kowalska et al., 2021)

The Kowalska Nutrients paper used cell-culture models of obesity-related dysfunction⁵. Lingonberry polyphenol and anthocyanin fractions were applied to:

• Hypertrophied 3T3-L1 adipocytes — modeling enlarged fat cells in obesity
• Human umbilical vein endothelial cells (HUVECs) stimulated with TNF-α — modeling early atherosclerosis

The polyphenol fraction reduced intracellular reactive oxygen species generation in the hypertrophied adipocytes. Both fractions inhibited expression of pro-inflammatory genes (VCAM-1, ICAM-1, MCP-1) in the endothelial cells. The work establishes plausible mechanisms for cardiovascular protection but stops at the in-vitro stage — no human cardiovascular endpoints were measured.

High-Fat Diet Model with Skin Extract (Ryyti et al., 2024)

The Ryyti 2024 study used lingonberry skin extract — a byproduct of juice production that concentrates the polyphenols — at a 5 percent dietary inclusion in C57BL/6 mice on a high-fat diet for six weeks⁶. Compared with high-fat-diet controls, lingonberry-supplemented mice showed partly prevented weight gain, lower epididymal fat accumulation, and lower fasting glucose. Glucose tolerance testing also improved. The use of byproduct skin extract is practically interesting because it suggests the bioactive load is concentrated in the parts of the berry typically discarded.

Macrophage Polarization (Ryyti et al., 2022)

The Ryyti Biomedicines study tested resveratrol, kaempferol, and proanthocyanidins individually for their effects on macrophage polarization⁷. All three pushed macrophages toward the anti-inflammatory M2 phenotype, which is associated with tissue repair and resolution of inflammation, rather than the pro-inflammatory M1 state. This is an in-vitro mechanistic finding, but it provides a coherent explanation for why a polyphenol-rich whole berry might lower systemic inflammatory markers in animal feeding studies.

Strength of Evidence

The evidence base for lingonberry sits at three different confidence levels depending on the claim:

• Urinary tract health: Moderate-to-strong evidence by extrapolation from cranberry, with one direct combined-berry RCT². The mechanism is well-characterized and the chemistry overlap is high¹.
• Glycemic and metabolic effects: Suggestive in humans (one small mechanistic crossover³), strong and consistent in animals^4,6, with plausible cellular mechanisms^5,7. Larger human trials are the obvious gap.
• Cardiovascular and anti-inflammatory effects: Mechanistic and animal evidence is solid^5,7, but human cardiovascular endpoint trials are essentially absent.

For a Nordic staple food, lingonberry is comparatively under-studied in humans relative to its closely-related cousin cranberry. The mechanistic and animal data is strong enough to support eating lingonberries as a regular part of a polyphenol-rich diet, while the strongest individual evidence sits with the urinary tract use it shares with cranberry.